APPLICATION OF ALPHA-FETOPROTEIN TO IDENTIFY PATIENTS WHO NEED ANTIVIRAL TREATMENT IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Huang, Yi-Hsiang [1 ,2 ]
Lee, I-Cheng [1 ]
Chan, Che-Chang [1 ,2 ]
Huo, Teh-la [1 ,3 ]
Su, Chien-Wei [1 ,2 ]
Lin, Han-Chieh [1 ]
Lee, Shou-Dong [1 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
[3] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
457
引用
收藏
页码：547A / 547A
页数：1
相关论文
共 50 条
  • [41] HBeAg-negative chronic hepatitis B: From obscurity to prominence
    Manesis, Emanuel K.
    JOURNAL OF HEPATOLOGY, 2006, 45 (03) : 343 - 346
  • [42] Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon
    Boglione, Lucio
    Cusato, Jessica
    Allegra, Sarah
    Esposito, Isabella
    Patti, Francesca
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    ANTIVIRAL RESEARCH, 2014, 102 : 35 - 43
  • [43] Evaluation of Hepatitis B Viraemia Levels in Patients with HBeAg-negative Chronic Hepatitis B Virus Infection
    Atay, A. E.
    Seven, G.
    Yalcin, K.
    Pasa, S.
    Degertekin, H.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (05) : 1891 - 1896
  • [44] Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA
    Zhou, Jing
    Wang, Fada
    Li, Lanqing
    Chen, Enqiang
    PRECISION CLINICAL MEDICINE, 2022, 5 (04)
  • [45] Evaluation of HBeAg-Negative Chronic Hepatitis B Patients Who Had Undergone Liver Biopsy in Accordance With the Guidelines
    Solak-Grassie, Semiha
    Gozutok, Funda
    Coskun, Belgin
    Dural, Sevinc
    Atakent, S. Deniz
    KLIMIK JOURNAL, 2018, 31 (01) : 37 - 40
  • [46] The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B
    Wong, Grace L. -H.
    Chan, Henry L. -Y.
    Yuen, Becky W. -Y.
    Tse, Yee-Kit
    Luk, Hester W. -S.
    Yip, Terry C. -F.
    Hui, Vicki W. -K.
    Liang, Lilian Y.
    Lee, Hye-Won
    Lui, Grace C. -Y.
    Wong, Vincent W. -S.
    LIVER INTERNATIONAL, 2020, 40 (03) : 549 - 557
  • [47] Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
    Garcia-Lopez, Mireia
    Lens, Sabela
    Pallett, Laura J.
    Testoni, Barbara
    Rodriguez-Tajes, Sergio
    Marino, Zoe
    Bartres, Concepcion
    Garcia-Pras, Ester
    Leonel, Thais
    Perpinan, Elena
    Lozano, Juan Jose
    Rodriguez-Frias, Francisco
    Koutsoudakis, George
    Zoulim, Fabien
    Maini, Mala K.
    Forns, Xavier
    Perez-del-Pulgar, Sofia
    JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1064 - 1074
  • [48] Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom
    Bermingham, Sarah L.
    Hughes, Ralph
    Fenu, Elisabetta
    Sawyer, Laura M.
    Boxall, Elizabeth
    Kennedy, Patrick T.
    Dusheiko, Geoff
    Hill-Cawthorne, Grant
    Thomas, Howard
    VALUE IN HEALTH, 2015, 18 (06) : 800 - 809
  • [49] Efficacy of the treatment of HBeAg-negative chronic hepatitis B patients with lamivudine: Results of 12 month therapy
    Seliverstova, T
    Isakov, V
    Bogomolov, P
    Mironova, O
    Pavlova, T
    Tsodikov, G
    Guschin, A
    HEPATOLOGY, 2002, 36 (04) : 637A - 637A
  • [50] Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B
    Papatheodoridis, GV
    Petraki, K
    Cholongitas, E
    Kanta, E
    Ketikoglou, I
    Manesis, EK
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) : 199 - 206
12345